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Electronic health record (EHR) data show promise for deriving new ways of modeling human disease
states. Although EHR researchers often use numerical values of laboratory tests as features in disease
models, a great deal of information is contained in the context within which a laboratory test is taken.
For example, the same numerical value of a creatinine test has different interpretation for a chronic
kidney disease patient and a patient with acute kidney injury. We study whether EHR research studies
are subject to biased results and interpretations if laboratory measurements taken in different contexts
are not explicitly separated. We show that the context of a laboratory test measurement can often be
captured by the way the test is measured through time.
We perform three tasks to study the properties of these temporal measurement patterns. In the ﬁrst
task, we conﬁrm that laboratory test measurement patterns provide additional information to the
stand-alone numerical value. The second task identiﬁes three measurement pattern motifs across a set
of 70 laboratory tests performed for over 14,000 patients. Of these, one motif exhibits properties that
can lead to biased research results. In the third task, we demonstrate the potential for biased results
on a speciﬁc example. We conduct an association study of lipase test values to acute pancreatitis. We
observe a diluted signal when using only a lipase value threshold, whereas the full association is
recovered when properly accounting for lipase measurements in different contexts (leveraging the lipase
measurement patterns to separate the contexts).
Aggregating EHR data without separating distinct laboratory test measurement patterns can intermix
patients with different diseases, leading to the confounding of signals in large-scale EHR analyses. This
paper presents a methodology for leveraging measurement frequency to identify and reduce laboratory
test biases.
 2014 Elsevier Inc. All rights reserved.1. Introduction
Millions of patients across the United States have extensive
medical histories stored in electronic form. This immense amount
of electronic health record (EHR) data provides a unique platform
to perform large-scale research studies of human health. Through
careful analysis of the variables in this vast dataset, researchers
can conduct a variety of multifaceted studies such as prediction
of future patient health state, evaluation of intervention effective-
ness, computational diseasemodeling, and identiﬁcation of danger-
ous drug–drug interactions [1–3]. Automating feature selection
from EHR variables is a difﬁcult task, as the EHR is an inherently
biased data source: EHR data are collected with the primary goalof delivering and documenting patient care, not with the primary
goal of creating a curated research dataset [4,5]. Identifying and
then mitigating such biases will result in not only the development
of more accurate methods for deriving computational models of
disease but also in learning better predictionmodels fromEHR data.
Currently, laboratory tests are one of themost widely-used features
in EHR disease-modeling research and are therefore the focus of
this paper.
In this work, we hypothesize that (i) the speciﬁc context of a
laboratory test order can be derived from EHR-observed measure-
ment patterns and (ii) that this context can be leveraged for better
disease modeling. While a laboratory test’s numerical values can
help distinguish healthy from sick patients, test values themselves
cannot separate sick patients by their ailment when the test is
associated with multiple diseases. For instance, while the numeri-
cal results may be comparable, the rate of measurement for a ges-
tational diabetes screening glucose test and a chronic diabetes
monitoring glucose test will differ greatly. We predict that how
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can help correctly separate one disease state from another. We fur-
ther hypothesize that laboratory test measurement patterns pro-
vide complementary and independent information from the
numerical values indicated by the laboratory tests. We formally
explore the relationship between both laboratory test measure-
ment gaps and laboratory test values to determine whether the
context in which a laboratory test is ordered alters the way its
value should be interpreted, and is therefore a critical feature for
disease modeling. While analyses of laboratory measurement pat-
terns have been conducted [6–9], the analyses and interpretations
have focused on resource overutilization and informing clinical
practice rather than on EHR-driven research.
Before describing our methods and ﬁndings, we provide back-
ground on laboratory testing from an informatics standpoint and
report on previous work in the emerging research area of EHR bias
identiﬁcation and mitigation.
1.1. Capturing the context of laboratory testing: reasons for ordering
and relationship to numerical values
At the point of patient care, different laboratory tests are ordered
at different rates, often dictated by what physiologic process the
test is measuring, and very often there exist multiple reasons for
ordering a particular laboratory test. The three most common rea-
sons for ordering a test are (i) diagnosing a condition, (ii) screening
for a condition, or (iii) monitoring a pre-existing condition. Some
laboratory tests are ordered for one speciﬁc, clinical reason: for
instance, the prostate-speciﬁc antigen (PSA) test is ordered exclu-
sively to screen patients for prostate cancer. Others serve multiple
clinical purposes: TSH, for instance, is used both to diagnose and
monitor patients with disorders associated with the thyroid hor-
mone. Finally, some tests, such as creatinine, are ordered both for
clinical purposes like monitoring chronic disease progression and
diagnosing acute conditions, and for healthcare process purposes
like following guidelines as part of a routine panel for preventive
testing [10]. When hospital protocol dictates measurement times,
as is the case with routine preventative panels, creatinine’s mea-
surement patterns arguably reﬂect healthcare processes more than
they reﬂect the health status of a patient. Thus, the context in which
a laboratory test is ordered depends both on its clinical purpose and
the surrounding healthcare processes.
Deriving the context of a laboratory measurement is a chal-
lenge, however. EHR data lack an explicit indication for why each
laboratory test was ordered, and using other dimensions of EHR
data for derivation of such information (such as ICD-9 codes and
clinical notes) is equally problematic. ICD-9 codes are notoriously
non-speciﬁc to patient disease state and are often not recorded
for all patient ailments [11,12]. Clinical notes rarely explicitly state
the exact reason a test has been ordered.
The speciﬁc description of the context in which a laboratory test
is measured, therefore, is not included in most computational
models of disease. In fact, most often models include only a labo-
ratory test’s numerical value, a range of values [13,14], or the pres-
ence or absence of a laboratory test [15] as features, but no
contextual information about the situation surrounding the order.
In this paper, we investigate whether aggregating numerical values
of laboratory tests taken in multiple separate contexts without
explicitly separating the contexts can lead to the confounding of
research conclusions.
In research with clinical data, there is an implicit assumption
that a laboratory test’s numerical value and the rate at which the
test is ordered are highly correlated features. This assumption
about value and measurement rate correlation likely stems from
the existence of value-based guidelines and the widespread expec-
tation that laboratory test values which fall outside of normalranges prompt intervention and retesting. Value-based guidelines
for laboratory test ordering dictate measurement frequency based
on a test’s numerical value. For instance, the guideline for perform-
ing a diagnostic PSA test states that if a patient’s PSA is slightly
over 4.0 ng/mL in the initial measurement, the PSA test should
be remeasured within 48 h to conﬁrm the need for a biopsy. Our
work formally investigates the linear and nonlinear relationship
between numerical value and measurement patterns in EHR-
recorded data.
1.2. EHR biases
EHR data are biased because they are gathered in an uncon-
trolled environment and are not carefully curated for research pur-
poses. EHR data are noisy, sometimes erroneous, and often sparse
[14]. At the same time EHR data contain sometimes conﬂicting
(e.g., notes and coded data provide differing medication lists) and
redundant information (e.g., clinicians often copy-and-paste from
previous notes). From a temporal standpoint, the EHR contains data
about elements that evolve at different time scales and often evolve
over time, as treatment affects patient state. Because of these com-
plexities, assessing the impact of EHR biases and correcting for their
impact on data-driven methods is an emerging research topic.
Recent research has shown that naïve EHR statistical analyses
can lead to the reversals of cause and effect [16], induction of spu-
rious signals [17], large errors when predicting optimal drug dos-
age [18], cancellation of temporal signals when aggregating
different cohorts [19–21], and model distortion when not account-
ing for redundancy in the narrative part of the EHR [22].
One particularly problematic bias inherent to the EHR is the
prevalence of data points that are missing not at random [23]
(e.g., patients are seen and measured more often when they are
sick, and measured less often when they are healthy). Inferring
missing information, such as values when the patient is not seen,
is a challenging research area. While there have been different
approaches to mitigating this type of missingness [14,24], mostly
researchers ignore missing values or interpolate them [25–27],
with some recent work on classifying which variables should be
interpolated and which should be ignored [28]. Lin and Haug dem-
onstrated that some missing values are themselves informative by
creating Bayesian networks that explicitly model the absence of
clinical variables; these models were able to predict medical prob-
lems better than those that ignored or interpolated missing values
[15]. Our work builds upon Lin and Haug’s ﬁndings and focuses on
leveraging the temporal missingness within laboratory measure-
ment data. We see the patterns of laboratory test measurement
as patterns of missing data. As a way to mitigate the EHR biases,
we explore the use of different missing-not-at-random patterns
to classify different patient health states and stratify heteroge-
neous populations into homogenous patient groups.2. Material and methods
Our study is carried out in three consecutive tasks, as described
below:
Task 1. We explored the correlation of laboratory values to the
laboratory test’s time to repeat, examining whether the value
and time between consecutive measurements (measurement
gap) encode separate information or overlap in information
content.
Task 2. To understand the overall dynamics of laboratory tests
recorded in the EHR, we categorized types of laboratory mea-
surement patterns, identifying those more likely to cause biases
in EHR-based research.
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surement can be used to account for biases in laboratory test
measurement data.
2.1. Ethics statement
This work was approved by the Columbia University Institu-
tional Review Board (IRB #AAAK7201). As it is impractical to col-
lect consent for such a large-scale study and the data is already
available through the in-house data warehouse, informed consent
was waived by the Institutional Review Board for this retrospective
research.2.2. Clinical data
We extracted patient records from the NewYork-Presbyterian
Hospital (NYPH) clinical data warehouse. We narrowed our popu-
lation to patients that have visited the NYPH Ambulatory Internal
Medicine clinic at least 3 times. The full longitudinal records (i.e.,
all inpatient and outpatient data points) for these patients were
gathered.
Three physicians reviewed and edited a list of frequently mea-
sured laboratory tests. They constructed a set of 70 laboratory tests
of interest to primary care and internal medicine. We extracted the
time series for these tests between September 1990 and September
2010 for all of the patients in the population.2.3. Task 1: Correlation between measurement gap and numerical
value
We quantiﬁed the relationship between value and measure-
ment gap, asking: in the patient population, is there added infor-
mation in looking at how a patient was measured, not only at
the measurement value? Given a particular laboratory test and
all patients’ time series for that test, we constructed a joint proba-
bility density function (PDF) using a kernel density estimate in
Matlab. The PDF consisted of laboratory values and time between
consecutive lab measurements (or gaps between measurements)
in days.
To assess the degree of correlation between a laboratory test’s
numerical values and its measurement gaps, we experimented
with (i) linear correlation (estimated at the 95% conﬁdence inter-
val) and an associated p-value and (ii) a non-linear measure of
correlation, mutual information (MI) between laboratory test val-
ues and gaps between measurements. Mutual information attains
a value of zero when the random variables underlying the
distributions (values and measurement patterns) are completely
independent. Mutual information attains a maximum when the
two distributions are deterministic functions of each other. In
the latter case, the mutual information is equal to the entropy
of the single equivalent distribution. Using the PDF, both the
linear correlation and mutual information were calculated for
the entire dataset (the full time scale) and separately for mea-
surements with long and short measurement gaps to capture dis-
tinct temporal dynamics at different time scales. The conﬁdence
interval estimates on the MI were made using a previously
described method [29]. By examining many measurement gap
histograms, we chose a heuristic cutoff of 3 days for what
constitutes a long gap and what constitutes a short gap: the short
time scale calculations only look at gaps and values where
consecutive measurements are taken no more than 3 days apart
and long time scale calculations look at gaps and values for
measurement gaps that are longer than 3 days.2.4. Task 2: Finding laboratory test measurement motifs
We explored the different types of laboratory test measurement
dynamics that exist in the EHR data by creating measurement gap
histograms for 70 different laboratory tests. We computed the fol-
lowing quantity: for each laboratory test taken on each patient, we
calculated the days between two consecutive measurements of
that laboratory test on that patient. A histogram was created for
each test, mapping the day gap between consecutive measure-
ments and number of such gaps, when aggregated across the entire
patient dataset. For example, if a patient had a creatine test taken
on February 3rd and another creatinine test taken on February 5th,
the count of creatinine tests with a measurement gap of 2 days
would be incremented by one.
We visualized the measurement gap histograms in different
coordinate systems to explore the measurement dynamics across
laboratory tests. We uncovered differences when examining the
histograms in the logarithmic coordinate system. Using log–log
coordinates, we visually looked for modes present in the histo-
grams. If there is linearity in a measurement gap histogram when
presented in log–log coordinates (i.e., a power-law) that implies
scale-free measurement dynamics and that all time scales repre-
sent a single context or reason for ordering the laboratory test. If
no approximately linear relationship between the frequency of
measurement gaps exists, we visually looked for changes (e.g.,
peaks) that separate the different dynamics patterns; these differ-
ent patterns may qualitatively imply different contexts of mea-
surement based on either a change in health state or based on
the healthcare documentation process. We catalogued the mea-
surement gap histograms based on observed approximate linearity
and the presence of peaks in the histograms, as determined by a
manual review of the curves.
2.5. Task 3: Studying the potential effect of measurement motifs on
research
In this task, we focus on a speciﬁc laboratory test as a use case for
studying the effect of measurement motifs on EHR-driven research.
For the use case, we chose to study lipase and acute pancreati-
tis. Acute pancreatitis is a well-understood condition and because
its diagnosis is largely laboratory-based it is a good test case to val-
idate our hypotheses. Both amylase and lipase tests have been used
for acute pancreatitis diagnosis but they are not speciﬁc for this
condition: both tests are also used for monitoring of chronic pan-
creatitis and diagnosing pancreatic cancer. We conducted all
experiments on both laboratory tests; in this paper, we focus on
lipase as recent literature has shown it to have higher diagnostic
sensitivity and speciﬁcity [30]. Our results for amylase were simi-
lar to those for lipase.
We asked the question: can the known association between an
abnormal lipase value and acute pancreatitis be recovered from
EHR data? To verify our hypothesis that laboratory measurement
dynamics can impact the accuracy of identifying patients with
acute pancreatitis, we considered three views of the data, based
on the dynamics of lipase measurements within each patient’s
record: (i) only visits with short lipase measurement gaps, (ii) only
visits with long lipase measurement gaps, and (iii) all visits inde-
pendent of the length between lipase measurements. In each of
these settings, we assessed the association between acute pancre-
atitis and lipase and studied the properties of visits that belong in
the setting using ICD-9 codes and clinical notes. We hypothesize
that as acute pancreatitis is an acute disease, visits with short
lipase measurement gaps will be more highly associated and rele-
vant to acute pancreatitis.
Fig. 2. The measurement gap histogram curve for the lipase laboratory test. The
measurement curve is presented on log–log scale as a histogram of the days
between consecutive lipase test measurements for each patient, aggregated across
the full population. We examined the ﬁgure visually and found that the pattern in
measurement gap frequency changes at approximately 3 days; after 3 days the
histogram curve is nearly linear. We used 3 days as a threshold for separating
measurements on a short time scale (0–3 days) from measurements on a long time
scale (over 3 days).
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We divided each patient record into individual visits (deﬁning a
full inpatient admission as one visit). Each record (represented as a
set of visits) was divided into bins of visits with short lipase mea-
surement gaps and visits with long lipase measurement gaps. Fig. 1
shows a schematic diagram of an individual’s longitudinal record:
visits 1 and 5 belong to the short-gap bin because the lipase mea-
surements were taken in rapid succession, the other visits belong
in the long-gap bin because they show a long time between con-
secutive lipase measurements.
To determine the threshold for how many days deﬁne a short-
gap and long-gap, we used the laboratory test’s measurement pat-
tern histogram. Under the hypothesis that peaks in the histogram
are indicative of the context within which a laboratory test is
ordered we use the location of peaks and trends around them as
thresholds for separating visits into short- and long-gap bins. This
visit-separationmethod is generally insensitive to the exact thresh-
old and is heuristically deﬁned for each laboratory test as a function
of the location and number of peaks in themeasurement histogram.
The measurement histogram of lipase (Fig. 2) had one peak at one
day and showed a change in measurement pattern at 3 days (the
lipase histogram is only nearly linear after the 3 day gap).
As there is only a measurement gap when a patient has two or
more tests, only patients with at least two lipase measurements
were included in the analysis. Similarly, no visits after the last
recorded lipase test were added to either bin. Our visit-binning
method is not limited to two (short- and long-gap) bins and there
can be more granular bins such as bins of regular weekly visits. InFig. 1. A schematic of a longitudinal record. A single patient’s longitudinal record is divided up into visits (represented here as a set of notes written during the visit) and visits
are binned into short or long gaps with respect to lipase measurements. For instance, the ﬁrst and ﬁfth visit are binned as short-gap visits, because they contain at least two
consecutive laboratory test measurements that occur within a short time period. Visits 2, 3, and 4 are long-gap visits because they occur between two consecutive lipase
measurements that are taken over a longer period of time.
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two distinct measurement patterns.
To analyze the differences between bins of short-gap measure-
ments and long-gap measurements, we separated all ICD-9 codes
and clinical notes created during short-gap lipase measurements
from those collected during long-gap bins. We conducted associa-
tion studies for lipase and acute pancreatitis in all three settings:
(i) only short-gap visits, (ii) only long-gap visits, and (iii) all visits.2.5.2. Analyses
To assess in what ways the visits with short lipase measure-
ment gaps differ from visits with long lipase measurement gaps,
we ran three analyses using ICD-9 codes and clinical notes. For
all of the following analyses, we used patients who exist in both
the short-gap and the long-gap bins. This ﬁltration reduced the
confounders and ensured that differences we uncovered were from
genuine separate health states. All p-values were Bonferroni-
corrected.Fig. 3. Density plots of the PDFs (consisting of laboratory values and time between cons
axis represents the log time to next measurement in days: log (1 h) = 1.38, log (1 day
different levels of correlation: LDL has no correlation on any time scale as shown by the
curve, Bicarbonate separates along two time scales while PSA is almost exclusively meaNote types. We looked at note types across the short and long
measurement gap bins. Note types can inform the status of the
patient. For example, a high frequency of admission and discharge
notes indicate many inpatient visits, while primary provider notes
are indicative of outpatient doctor visits. We performed a chi-
squared test to assess the strength of association between the fre-
quency of each note type and the gap bin; this test was chosen
because we are comparing counts across different bins.
Note content. We analyzed the frequency and coverage of all
words across the notes in each bin. Differences in note content
indicate differences in topics and hint at different contexts of mea-
surement across gap bins. To correct for the redundancy within
notes, we calculated word coverage. Redundancy across notes
within a patient was implicitly handled, as individual patient
records were divided into both bins. We look at the note content,
both frequency and coverage, to check the separation created by
long and short lipase gaps. The presence of certain words that
relate to speciﬁc health states can hint at the level of separationecutive measurements) for four laboratory tests shown on the full time scale. The x
) = 0, log (1 week) = .85, log (1 month) = 1.47, log (1 year) = 2.56. Each graph shows
mostly round ball, HbA1c has a negative correlation as shown by the L-shape of the
sured on the long time scale of over a year between consecutive measurements.
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of the patient’s record are indeed being separated out.
For each word we calculated:
Frequency¼# times the word appears across all notes in the gap bin
total# of words across all notes in the gap bin
Coverage¼# notes in which the word appears
total# of notes in the gap bin
We performed a chi-squared test to assess the strength of associa-
tion between the coverage of each word and the gap bin.
Association study. To test whether laboratory measurement
dynamics affect a typical EHR association study [31], we conducted
a phenome-wide search using the binomial test to ﬁnd ICD-9 codes
associated with an elevated lipase. For every ICD-9 code, we
compared its frequency of occurrence with high lipase in all three
settings. The binomial test was used to assess the statistical
signiﬁcance of deviations due to high lipase from the expected
distribution of ICD-9 codes. The variables were deﬁned as follows,
per ICD-9:
H0 : PðICD-9Þ ¼ # visits where the ICD-9 is recorded
# visits where a lipase lab test is done
# trials ¼ # visits where median lipase > 43
# successes ¼ # visits where ðmedian lipase > 43 AND the ICD
 9 is recordedÞFig. 4. A Bayesian network describing the two factors that inﬂuence a laboratory
tests measurement pattern. The extent to which each factor contributes, changes
which motif the test belongs to, thereby changing how it can be used in research
settings. The ‘‘mixed in- and outpatient’’ motif represents laboratory tests taken
across patients with multiple health states. Laboratory tests with mixed motifs may
contribute to biased results when computing over the multiple health states as one
population of patients.3. Results
Our ﬁnal dataset consisted of 14,141 patients, their notes, ICD-9
codes, and laboratory test times and values for 70 tests, spanning
20 years. On average each patient had 150.4 ICD9 codes [95% CI:
147.7–153.1], 825.8 laboratory tests [95% CI:807.7–847.0], and
133.5 clinical notes [95% CI: 130.8–136.3] over the entire study
period.
3.1. Task 1: Correlation between measurement gap and numerical
value
Both correlation metrics, linear and non-linear (through mutual
information), between measurement patterns and test values were
carried out for the 70 laboratory tests (see Appendix Tables 1 and 2
for full results). When we did not separate by time scale, there was
little correlation: with the linear measure, all laboratory tests had a
correlation very close to zero. With the mutual information mea-
sure, although also very low, a few laboratory tests demonstrated
some level of correlation. The highest mutual information was .15,
detected for the albumin laboratory test and only nine other tests
had a mutual information higher than 0.1 (see Appendix Tables 1
and 2). Overall, these very low correlations indicate that there is
separate information encoded in the laboratory test measurement
pattern and the laboratory test’s numerical value.
Exploring the correlation statistics separately for different time
scales (short and long gaps), some laboratory tests such as LDL
displayed no correlation (Fig. 3(a)), using either metric, on any
time scale, while other laboratory tests such as HbA1c and creati-
nine, showed some degree of correlation. For LDL, the numerical
value does not affect its testing rate. We interpret the absence of
correlation in measurement patterns and value as a result of
healthcare process, such as adherence to guidelines for testing
[32]. HbA1c displays a clear negative linear correlation of 0.193
only on the slow time scale, a higher HbA1c value is correlated
to a shorter time until next measurement (Fig. 3(b)). Creatinine
also displays a clear negative linear correlation of 0.208, but on
the short time scale.The results from the linear correlation calculations were consis-
tent with earlier work on the relationship between laboratory
value and measurement frequency [8]. Weber and Kohane
assigned categories to laboratory tests based on how numerical
values were perceived (e.g.: ‘‘Bad–Good’’ represented a laboratory
test where a low value was bad, and a high value was good). In our
work, a positive linear correlation indicates a ‘‘Bad–Good’’ test
where a low value prompts rapid retesting and a high value has
a longer measurement gap, similarly a negative linear correlation
represents a ‘‘Good–Bad’’ test.
The interplay between correlations on the full time scale and
separately on the short and long time scales revealed interesting
ﬁndings about measurement dynamics. For example, bicarbonate
showed a positive linear correlation on both long and short time
scales (the higher the value, the longer the gap between measure-
ments), but when aggregating the time scales together and com-
puting the total linear correlation, the correlation disappeared
(Fig. 3(c)). By contrast, the PSA screening test had very similar
mutual informations on the full and long time scales. The differ-
ences between tests such as bicarbonate and the PSA screening test
hint at differences in the contexts in which laboratory tests are
ordered (Fig. 3(d)). As PSA is measured in a single context, it is
not subject to signal dilution due to timescale aggregation. Alterna-
tively, the correlation results for laboratory tests such as bicarbon-
ate, which are measured for multiple reasons and in various
contexts, indicate that it is sometimes necessary to separate labo-
ratory measurements by underlying context of measurement.3.2. Task 2: Laboratory test measurement motifs
Manual cataloguing of the measurement gap histograms for 70
laboratory tests uncovered a set of three motifs that were most
common. The three motifs of laboratory test ordering are inﬂu-
enced by two factors: patient health state and the healthcare pro-
cess (Fig. 4). These two factors contribute to create the shape of the
laboratory test’s histogram. Certain histogram motifs highlight the
presence of multiple contexts in which the test is being ordered.
The histogram shape can determine whether further population
stratiﬁcation is necessary for conducting analyses or whether the
laboratory measurements already represent a mostly homogenous
patient set. The contributions of the patient health state and the
healthcare process is dependent on the laboratory test itself and
deﬁne the three motifs of test ordering: (i) primarily inpatient,
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Fig. 5 shows typical graphs from each of these three categories.
In general, laboratory tests that show peaks at very short time
gaps in their measurement histograms are representative of tests
taken during inpatient stays; laboratory tests with measurement
graphs that peak at longer gaps of a few months are representative
of measurements obtained during an outpatient visit. For some
tests, the documentation (outpatient vs. inpatient) reason is
aligned with the clinical reason; related to the fact that the numer-
ical value obtained from a particular test is valid for a speciﬁc time
period only. For example, troponin levels are representative of a
patient state at the hour level, and thus their measurements are
on the timescale of days. Because troponin is measured for patients
suspected of suffering a myocardial infarction, and such a diagnosis
has a high rate of inpatient admission, the troponin measurement
dynamics are representative of an inpatient stay. Troponin’s mea-
surement dynamics represent a primarily inpatient laboratory test,
motif (i).
Other laboratory tests such as microalbumin and HbA1c change
at a slower time scale and are ordered primarily in outpatient set-
tings; as the values change slowly, there is no need to repeat their
measurement during a short-term hospital admission. Therefore,
HbA1c and microalbumin measurement dynamics represent pri-
marily outpatient visits, motif (ii).
Laboratory tests that follow motif (iii) represent a set of tests
whose measurement dynamics result from a mixture of both clin-
ical and documentation reasons. For instance, glucose changes rap-Fig. 5. Representative examples of the three measurement gap motifs identiﬁed. Each lab
consecutive test measurements for each patient, aggregated across the full population. (i)
displays an approximately linear relationship in the coordinate system; (ii) HbA1c is
distribution around 91 days; (iii.a) Glucose represents a mixture of in- and outpatient m
scale (less than 10 days) and another peak at long time scales (multiple months); (iii.b) Tr
different mixture type: triglycerides has a high outpatient component and shows two diffidly and is widely used in inpatient settings to monitor short-time
scale changes but is also a regular test performed during outpatient
visits to monitor chronic diabetics. The glucose dynamics are evi-
dent by the histogram diagram in Fig. 5 where there is a fast time
scale peak at 1 day, and a smaller slow time scale peak at 91 days.
The peak at 91 days shows quarterly patient monitoring. Many
other laboratory tests have motif (iii) measurement dynamics:
for example, creatinine displays an almost identical histogram as
glucose because they belong on the same basic metabolic panel
and lipase along with amylase also have a mixture motif because
of their use in both inpatient settings for acute events and outpa-
tient settings for long-term monitoring.
Triglycerides is also a laboratory test with a mixture motif but
with very different mixture weight (iii.b). This type of mixture lab-
oratory test represents a dynamic that is also a result of mixed doc-
umentation and clinical reasons but with much heavier weight on
the outpatient component mixing. Most of the population receives
triglycerides at 3-month time scales to assess heart health but a
small subset of patients have their triglycerides monitored on a
much shorter time scale, these are ICU patients with feeding tubes.
The large portion of outpatient testing is seen in the triglycerides
measurement gap histogram because the peak at 91 days is at a
similar height as the peak at 1 day.
These three laboratory measurement motifs determine how to
use different laboratory tests in EHR research. The tests for which
clinical and documentation reasons align (laboratory tests used
almost exclusively for inpatients or outpatients) represent aoratory test motif is presented on a log–log scale as a histogram of the days between
Troponin represents a primarily inpatient laboratory test, with a peak at 0 days and
an example of a primarily outpatient laboratory test, showing a highly peaked
easurements, evidenced by the complex histogram: a high peak at on a short time
iglycerides is another example of mixed laboratory test dynamics but with a slightly
erent time scale peaks with a large quantity of measurements on the long time scale.
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tests in motif (i) or (ii), aggregating across patient values is a safe
approach. In contrast, the laboratory tests with the mixedmeasure-
ment motifs, might represent several separate patient states (such
as patients receiving triglyceride measurements as outpatient
patients and patients receiving triglyceride measurements as ICU
patients). Aggregating patient’s values without separating the dif-
ferent patient state contexts in a large-scale study may introduce
biases. The next section shows results of selecting patient cohorts
by relying on a laboratory test with mixed dynamics (lipase) and
how it impacts disease modeling (acute pancreatitis).3.3. Task 3: Measurement patterns highlight clinical state
We considered the histograms of measurement dynamics as
plots of missing measurements. We presumed that for laboratory
tests in the mixed motif category (iii), the data are missing not at
random and may be informative of the patient’s health state. Fol-
lowing intuition from Little’s pattern mixture models [33] we
hypothesized that different missing data patterns (or varying gaps
between measurements) deﬁne different health states.
We explored this idea using lipase and hypothesized that (i)
lipase measurement dynamics indicate two distinct missing values
patterns, each representative of a clinical condition, rather than a
documentation state and (ii) separating the dataset by missingness
patterns (visits with short gaps between measurements vs. visits
with long gaps between measurements) helps recover the associ-
ation between elevated lipase and the health state of acute
pancreatitis.Table 2
Words associated with a pancreatitis health state are more frequently found in the short ga
more concentrated on the pancreatitis diagnosis into the 0–3 day measurement gap. The ra
in coverage between the two bins is shown in this table. The words with a larger than 1%
Frequency of Words in Each Bin
0–3 Day measurement gap 3+ D
Words Raw frequency %Total words % Notes containing
that word
Raw
pancreatitis 10,732 0.14 6.94 13,3
lipase 4908 .06 4.28 972
amylase 3855 .05 3.48 98,2
withdrawal 4139 .05 2.80 12,5
librium 3303 .04 2.00 606
pancreatic 4393 .06 2.76 15,9
epigastric 3668 .05 2.92 15,7
Table 1
Note types indicative of healthcare setting (in vs. outpatient) are spread across short and lo
of healthcare, but rather of health states. This table shows the top 10 normalized differences
in % total note types.
Frequency of note types in each bin
Note type 0–3 Day measurement gap
Raw frequency % Total note ty
Signout 6269 0.144
Miscellaneous Nursing Note 4443 0.102
12-Lead Electrocardiogram 2126 0.049
X-ray of Chest, Portable 1460 0.034
Discharge Summary 783 0.018
Progress Note 837 0.019
Adult Social Work Progress Note 662 0.015
Physical Therapy 605 0.014
Admission Note 579 0.013
Respiratory Care Patient Assessment 512 0.0123.3.1. Note types
The note-type analysis indicated a signiﬁcant difference
between the common note types used in the short-gap and long-
gap bins. The note types in Table 1 showed that lipasemeasurement
dynamics can highlight true clinical differences, rather than docu-
mentation differences between inpatient and outpatient visits.
There are note types that are only written during inpatient
stays: an admission note, a signout note during a hospital shift
change, and a discharge note. If separating visits based on lipase
measurement dynamics was separating on a purely documenta-
tion basis with inpatient visits in the short-gap bin and outpatients
in the long-gap bin, we would expect these inpatient-speciﬁc notes
to be exclusively present in the short-gap bin. Instead, there are
more inpatient notes in the longer gap bin but the coverage of
inpatient notes is larger in the 0–3 day bin; the signout, admission,
discharge account for 14%, 2%, and 1% of the total note-types,
respectively. The long-gap bin contains a large amount of inpatient
data demonstrating that the laboratory test measurement dynam-
ics are able to isolate visits based on health not hospital status in
the short-gap bin. The note types present in the short-gap bin
are relevant for diseases associated with lipase measurement as
well. Elevated lipase often leads to testing for inﬂamed pancreas
by ordering Ultrasound scans, CT scans, ERCP or Chest X-Rays.
Common note-types for all 4 procedures were signiﬁcantly more
frequent in the 0–3 gap bin and ranked in the top 10% of Table 1.
The results from the note type analysis suggest that lipase mea-
surement dynamics are able to separate by patient health status
and ﬁnd speciﬁc visits that more likely pertained to acute pancre-
atitis events.p bins, suggesting that the separation is grouping notes written during visits that are
w, normalized, and coverage frequencies of words in each gap sorted by the difference
difference are shown, each of the words shown is highly associated with the 0–3 gap.
ay measurement gap
frequency %Total words % Notes containing
that Word
Difference in
coverage
03 0.01 1.41 5.52
8 0.01 1.50 2.79
46 0.01 1.30 2.19
62 0.01 1.28 1.52
4 0.00 0.59 1.42
92 0.01 1.38 1.38
67 0.01 1.89 1.04
ng gap bins, hinting that the measurement gap-based separation is not representative
in % of total note types in each bin, each has a highly statistically signiﬁcant difference
3+ Day measurement gap Difference in %
pes Raw frequency %Total note types
21,345 0.039 0.105
14,944 0.027 0.075
9217 0.017 0.032
3901 0.007 0.027
3030 0.006 0.012
3937 0.007 0.012
2383 0.004 0.011
2325 0.004 0.010
2154 0.004 0.009
1434 0.003 0.009
Table 3
The actionable measurement gap separation method for ﬁnding and removing a
confounding bias in laboratory test EHR data.
Measurement gap separation method
Step Action Motivation
1 Plot a histogram of the frequency
and measurement gap in log–log
coordinates
The histogram provides a method
to visually examine the laboratory
tests measurement dynamics
2 Examine the modality of the plot;
looking for multi-modality
If the histogram is multi-modal, it
may imply a difference in patient
health states or a healthcare
process bias
3 If there are multiple peaks, deﬁne
a measurement gap threshold to
separate the peaks
This separation deﬁnes multiple
settings for the EHR experiment,
creating sets of homogenous data
points with respect to their
measurement gaps
4 Perform the EHR experiment
separately for each setting
Separately performing
experiments for different settings
may remove confounding bias
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The words with the largest difference in coverage between the
short-gap and long-gap bins are very relevant to pancreatitis
(Table 2): both lipase and amylase can be used to diagnose pancre-
atitis, Librium is an anti-anxiety drug often given to alcoholic
patients with withdrawal symptoms, and alcoholic patients often
have pancreatitis. There are more references to ‘‘pancreatitis’’ in
the long-gap bin but the normalized frequency and coverage of
the word is much higher in the short-gap bin. This indicates that
the notes written during shorter gaps in measurement are more
focused on the pancreatitis diagnosis.
The word ‘‘pancreatic’’ modiﬁed ‘‘cancer’’ with a high preva-
lence in both gaps. This results from many patients with long-term
pancreatic disorders experiencing acute episodes during their ill-
ness. We found that the word ‘‘cancer’’ has a coverage and fre-
quency about 3 times higher in the long-gap bin than in the
short-gap bin.
3.4. Recommendation for EHR research with laboratory measurements
Knowing that acute pancreatitis is associated with high lipase
levels, we used the binomial test to investigate whether separating
visits by lipase measurement gaps highlight this association more
prominently. In each setting, we performed a phenome-wide anal-
ysis to see the association between high lipase and ICD-9 577.0
(Acute Pancreatitis).
In the 0–3 day gap setting, the binomial test found the top asso-
ciation to be acute pancreatitis with an extremely signiﬁcant Bon-
ferroni corrected p-value of < 1 10234. In the other two settings
(greater than 3 day gap, and no separation by gaps), acute pancre-
atitis was also found to be the top association but with a much
smaller p-value (Fig. 6). The long-gap setting had the smallest asso-
ciation and therefore the no separation setting also showed a much
lower p-value. These p-value differences demonstrate that signal
dilution is a consequence of ignoring measurement frequency bias
during phenome-wide analyses. The process of binning laboratoryFig. 6. The results of a binomial association test between high lipase and ICD-9 cod
measurements of 0–3 days, long gaps of more than 3 days, and all visits regardless of gaps
For illustration purposes, the ICD-9 codes are sorted by association to high lipase in thevalues by their gaps between measurements (Table 3) can reduce
confounding by not mixing different patient health states.
Our results also demonstrate the generalizability of this mea-
surement gap separation method. The measurement bins, created
based on lipase measurement dynamics, were able to differentiate
levels of association in other diseases as well. Type II diabetes
(which may reﬂect clinicians screening type II diabetics with high
triglycerides for pancreatitis) and HIV were differently associated
with each setting. Without the lipase measurement-based separa-
tion of visits these disease associations are confounded by the bias
of short-term lipase measurements. Interestingly, the ICD-9 for
chronic pancreatitis is similarly associated with all three settings.
The consistency of chronic pancreatitis is from patients having
acute episodes during their chronic illness, conversely, not all acute
pancreatitis patients have chronic pancreatitis. This asymmetry ises. The binomial test was performed in all three settings (short gaps between
between lipase measurements). The top 20 most signiﬁcant associations are shown.
3 + days gap.
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pancreatitis.
4. Discussion
EHR research studies rely heavily on laboratory tests and their
numerical values. We studied how laboratory test’s pattern of
measurements may provide additional information to a laboratory
test’s values. We discovered there is very limited correlation
between how often a test is ordered and the value of the test. This
lack of correlation implies that the value and measurement gap are
informationally orthogonal to each other and are both important
features to include when looking at laboratory tests, and speciﬁ-
cally when using laboratory tests as features to represent patient
disease state. In addition, there is evidence of different correlation
results when examining laboratory test values on different time
scales, showing that temporality plays a crucial role in the use of
clinical laboratory test data.
We found evidence that measurement patterns of laboratory
tests are dictated by clinical and physiological knowledge, but
often confounded by the healthcare process, such as hospital doc-
umentation practices whether from workﬂows or guidelines.
One clear artifact of hospital document patterns was revealed
by examining the measurement gap histograms of 70 laboratory
tests. Many laboratory test histograms have peaks at exactly
91 days, although their histogram height is varied. Our hospital
serves a highly captive and sick population of patients in the sur-
rounding neighborhoods. As the population is sick, 3 month check-
ups are a common practice and as the population lives nearby, the
general adherence to a strict 3 month (91 day) schedule is high. It
is clear that this 91 day peak is caused by the operations of the hos-
pital and makeup of the population – not the clinical state of each
individual patient. Although this particular healthcare process bias
is speciﬁc to our institution, we postulate similar types of biases
exist across the country and should be mitigated before using the
EHR-recorded data for research.
Upon cataloguing all 70 laboratory tests we uncovered three
types of measurement dynamics motifs, one which represents
‘‘mixed’’ laboratory tests where clinical factors and documentation
standards are misaligned.
4.1. Separation of mixed motif laboratory tests by measurement
pattern mitigates EHR laboratory bias
Laboratory tests with multiple ordering reasons, such as those
used for both diagnosis and monitoring, present challenges to
EHR-based research. When using laboratory values without
accounting for the laboratory test’s frequency of measurement,
confounders can dilute the results of a study. The dynamics of lab-
oratory measurement gaps across a population can reveal different
measurement patterns present in the data; examining the mea-
surement patterns of a particular test and then performing patient
record decomposition in a strategic manner reduces signal dilu-
tion. For example, ﬁltering the full patient cohort by visits within
a particular measurement pattern of missingness will provide a
more focused dataset of patient states.
We demonstrated our method of visit separation through mea-
surement gap analysis on lipase as a speciﬁc use case. Using note
types, note content, and ICD-9 codes we showed that our method
could group inpatient visits pertinent to a particular clinical condi-
tion (acute pancreatitis in our example) away from inpatient visits
pertinent to other clinical reasons. We also performed a secondary
analysis to test that separating on hospital status does not yield the
same results as separating by measurement gap. When looking
exclusively at inpatient visits (without accounting for measure-ment gap), the association between high lipase and acute pancre-
atitis was only as high as the ‘‘3 + Days’’ association found using
the measurement gap separation method (Fig. 6). Therefore, we
infer that the measurement gap separation method can indeed
separate on health status, not simply healthcare process.
The work presented in this paper is highly relevant to research-
ers working on cohort identiﬁcation algorithms, especially with the
recent push for more automated ways to perform high-throughput
phenotyping [34–36]. We present the stratiﬁcation of an individ-
ual’s medical record by laboratory test measurement frequency
as a new conceptual paradigm for studying EHR data with EHR-
recorded laboratory tests.
4.2. Limitations
This study is carried out on a single institution. While the pop-
ulation under study was large, future work is to replicate these
ﬁndings on a population from a different institution. We also
acknowledge the limitation of using only one test to demonstrate
laboratory test biases, but we present the lipase and acute pancre-
atitis association study as a single proof-of-concept example to
exhibit the potential importance of separating laboratory test val-
ues by measurement pattern. Furthermore, the study is limited due
to changing hospital documentation and clinical best practices.
These changes may dictate the frequency tests should be ordered
and their purpose (such as the transition from amylase to lipase
as the recommended diagnostic test for acute pancreatitis), leading
to variable results across different time periods. We conducted an
informal investigation and found few differences in dynamics
across time periods, although not enough to affect the overall
results of the study.
5. Conclusion
For the re-use of clinical data to facilitate novel data-driven
informatics research, understanding salient features and correcting
for EHR biases is a necessary step. We show that surprisingly, there
is often little shared information between laboratory test values
and the laboratory test’s rate of measurement in time. Further,
measurement patterns are useful features to use in disease model-
ing and they can result from a combination of hospital workﬂow
practices and clinical states. When the clinical and documentation
biases are not in concert (as is often the case with laboratory tests
used for multiple purposes), EHR-driven association studies may
produce biased results. We catalogued the measurement dynamics
of laboratory tests into three motifs, one of which has mixed pat-
terns of measurement and is prone to biases. Finally, we demon-
strate how to control for the biases by disambiguating patient
health states based on laboratory measurement frequency, using
the laboratory test lipase and acute pancreatitis as an illustrative
example.
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